Health and Fitness Health and Fitness
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Health Net Promotes Thomas Carrato to President of Health Net Federal Services
[ Mon, Oct 24th 2011 ] - Market Wire
Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector
[ Mon, Oct 24th 2011 ] - Market Wire
Highly Scrutinized Medical Equipment and Supplies Sector Looks for FDA Clarity
[ Mon, Oct 24th 2011 ] - Market Wire
NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
[ Mon, Oct 24th 2011 ] - Market Wire
PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials
[ Mon, Oct 24th 2011 ] - Market Wire
Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now
[ Mon, Oct 24th 2011 ] - Market Wire
SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a
[ Mon, Oct 24th 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure
[ Mon, Oct 24th 2011 ] - Market Wire
Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow
[ Mon, Oct 24th 2011 ] - Market Wire
Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation
Sat, October 22, 2011
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon
[ Sat, Oct 22nd 2011 ] - Market Wire
Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS
[ Sat, Oct 22nd 2011 ] - Market Wire
Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC
Fri, October 21, 2011
[ Fri, Oct 21st 2011 ] - Market Wire
Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P
[ Fri, Oct 21st 2011 ] - Market Wire
Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America
[ Fri, Oct 21st 2011 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp
[ Fri, Oct 21st 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger
[ Fri, Oct 21st 2011 ] - Market Wire
Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance
[ Fri, Oct 21st 2011 ] - Market Wire
Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan
[ Fri, Oct 21st 2011 ] - Market Wire
AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si
[ Fri, Oct 21st 2011 ] - Market Wire
For The Earth Corporation Strengthens Its Portfolio With Kat Box King
[ Fri, Oct 21st 2011 ] - Market Wire
GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 21st 2011 ] - Market Wire
Magellan Health Services to Present at Academy of Managed Care Pharmacy Educational Conference
[ Fri, Oct 21st 2011 ] - Market Wire
Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d
[ Fri, Oct 21st 2011 ] - Market Wire
Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE
[ Fri, Oct 21st 2011 ] - Market Wire
Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS
[ Fri, Oct 21st 2011 ] - Market Wire
Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):
[ Fri, Oct 21st 2011 ] - Market Wire
Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi
Thu, October 20, 2011
[ Thu, Oct 20th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Successfully Completes Critical Study
[ Thu, Oct 20th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals
[ Thu, Oct 20th 2011 ] - Market Wire
Dendreon Announces Webcast Presentations at Upcoming Conferences
[ Thu, Oct 20th 2011 ] - Market Wire
Biogen Idec and Elan Receive Notification of PDUFA Date Extension
[ Thu, Oct 20th 2011 ] - Market Wire
Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference
[ Thu, Oct 20th 2011 ] - Market Wire
Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial
[ Thu, Oct 20th 2011 ] - Market Wire
POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results
[ Thu, Oct 20th 2011 ] - Market Wire
Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial
[ Thu, Oct 20th 2011 ] - Market Wire
Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion
[ Thu, Oct 20th 2011 ] - Market Wire
Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System
[ Thu, Oct 20th 2011 ] - Market Wire
Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter
[ Thu, Oct 20th 2011 ] - Market Wire
Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th
[ Thu, Oct 20th 2011 ] - Market Wire
Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw
[ Thu, Oct 20th 2011 ] - Market Wire
Device Master File for OncoSec Medical System Completed and Submitted to FDA
[ Thu, Oct 20th 2011 ] - Market Wire
Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service
Wed, October 19, 2011
[ Wed, Oct 19th 2011 ] - Market Wire
Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call
[ Wed, Oct 19th 2011 ] - Market Wire
Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b
[ Wed, Oct 19th 2011 ] - Market Wire
Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t
[ Wed, Oct 19th 2011 ] - Market Wire
Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun
[ Wed, Oct 19th 2011 ] - Market Wire
Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
[ Wed, Oct 19th 2011 ] - Market Wire
Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50
[ Wed, Oct 19th 2011 ] - Market Wire
Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist
[ Wed, Oct 19th 2011 ] - Market Wire
Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting
[ Wed, Oct 19th 2011 ] - Market Wire
UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE
[ Wed, Oct 19th 2011 ] - Market Wire
Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me
[ Wed, Oct 19th 2011 ] - Market Wire
Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics
[ Wed, Oct 19th 2011 ] - Market Wire
Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders
[ Wed, Oct 19th 2011 ] - Market Wire
Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI
[ Wed, Oct 19th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th
[ Wed, Oct 19th 2011 ] - Market Wire
Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin
Tue, October 18, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.
[ Tue, Oct 18th 2011 ] - Market Wire
Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011
[ Tue, Oct 18th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th
[ Tue, Oct 18th 2011 ] - Market Wire
Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call
[ Tue, Oct 18th 2011 ] - Market Wire
Allon Therapeutics Completes Equity Offering
[ Tue, Oct 18th 2011 ] - Market Wire
Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles
[ Tue, Oct 18th 2011 ] - Market Wire
MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate
[ Tue, Oct 18th 2011 ] - Market Wire
Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
[ Tue, Oct 18th 2011 ] - Market Wire
Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases
[ Tue, Oct 18th 2011 ] - Market Wire
Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding
[ Tue, Oct 18th 2011 ] - Market Wire
Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer
[ Tue, Oct 18th 2011 ] - Market Wire
Greystone Logistics Announces Preliminary Financial Results for 1st Quarter
[ Tue, Oct 18th 2011 ] - Market Wire
DaVita Announces Estimate of Third Quarter 2011 Results
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Elects Michael O. Leavitt to the Board of Directors
[ Mon, Oct 17th 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals
[ Mon, Oct 17th 2011 ] - Market Wire
Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
DMRJ Amends Implant Sciences' Credit Facility
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M
[ Fri, Oct 14th 2011 ] - Market Wire
MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Amarillo Biosciences Issues Corporate Update
[ Fri, Oct 14th 2011 ] - Market Wire
Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors
[ Fri, Oct 14th 2011 ] - Market Wire
New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
[ Fri, Oct 14th 2011 ] - Market Wire
Dynavax to Present at Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
MSA Completes Sale of North Carolina Ballistic Vest Business
[ Fri, Oct 14th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.
[ Fri, Oct 14th 2011 ] - Market Wire
Teva Completes Acquisition of Cephalon
[ Fri, Oct 14th 2011 ] - Market Wire
Funding Security Critical to Long Term Success of Biotech Firms
[ Fri, Oct 14th 2011 ] - Market Wire
Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M
[ Fri, Oct 14th 2011 ] - Market Wire
Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st
Thu, October 13, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Kindred Healthcare Commences Registered Exchange Offer for Its 8.25% Senior Notes Due 2019
[ Thu, Oct 13th 2011 ] - Market Wire
Trimel Appoints John Friedrichsen to Its Board of Director
[ Thu, Oct 13th 2011 ] - Market Wire
Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011
[ Thu, Oct 13th 2011 ] - Market Wire
Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off
[ Thu, Oct 13th 2011 ] - Market Wire
Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors
[ Thu, Oct 13th 2011 ] - Market Wire
Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger
[ Thu, Oct 13th 2011 ] - Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire
[ Thu, Oct 13th 2011 ] - Market Wire
Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL
[ Thu, Oct 13th 2011 ] - Market Wire
Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States
[ Thu, Oct 13th 2011 ] - Market Wire
U.S. Sales of EGRIFTA(R) Driving Revenue Growth
[ Thu, Oct 13th 2011 ] - Market Wire
Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
[ Thu, Oct 13th 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise
[ Thu, Oct 13th 2011 ] - Market Wire
China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
[ Wed, Oct 12th 2011 ] - Market Wire
Mylan Announces Intention to Refinance Existing Secured Credit Facility
[ Wed, Oct 12th 2011 ] - Market Wire
Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation
[ Wed, Oct 12th 2011 ] - Market Wire
Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors
[ Wed, Oct 12th 2011 ] - Market Wire
DiaMedica's DM-199 and DM-204 Both Named to Windh .. op 10 Cardiovascular/Metabolic Projects to Watch"
[ Wed, Oct 12th 2011 ] - Market Wire
Ceapro Announces Signing of a Sales Agreement Wit .. s Inc. for its certified All-Natural Active Ingre
[ Wed, Oct 12th 2011 ] - Market Wire
OPKO Completes Sale of Ophthalmic Instrumentation Business
[ Wed, Oct 12th 2011 ] - Market Wire
Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm
[ Wed, Oct 12th 2011 ] - Market Wire
Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death
[ Wed, Oct 12th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation
[ Wed, Oct 12th 2011 ] - Market Wire
Galectin Therapeutics Elects Dr. Marc Rubin to its Board of Directors
[ Wed, Oct 12th 2011 ] - Market Wire
Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Molina Healthcare of Missouri Receives aCommendablea? NCQA Status
[ Tue, Oct 11th 2011 ] - Market Wire
St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen
[ Tue, Oct 11th 2011 ] - Market Wire
Healthnostics Launching MicroFill-2160 1st Quarter 2012
[ Tue, Oct 11th 2011 ] - Market Wire
INCIVEKa" (t©lapr©vir) disponible au Canada pour le traitement de l'h©patite C
[ Tue, Oct 11th 2011 ] - Market Wire
GlycoMimetics and Pfizer Enter into Licensing Agr .. rently in Development to Treat Patients Experienc
[ Tue, Oct 11th 2011 ] - Market Wire
Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter
[ Tue, Oct 11th 2011 ] - Market Wire
Vanguard Health Systems Appoints Carol Burt to Board of Directors
[ Tue, Oct 11th 2011 ] - Market Wire
Cyanotech Announces 33% Expansion of Astaxanthin Production Capacity
[ Tue, Oct 11th 2011 ] - Market Wire
International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal
[ Tue, Oct 11th 2011 ] - Market Wire
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program
[ Tue, Oct 11th 2011 ] - Market Wire
Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
[ Tue, Oct 11th 2011 ] - Market Wire
Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
Electromed, Inc. Introduces aSeriously Pinka to Its SmartVest® Product Line
[ Mon, Oct 10th 2011 ] - Market Wire
Dynavax Reports Positive Immunogenicity Data From .. ponsive Populations in HEPLISAV(TM) Phase 3 Trial
[ Mon, Oct 10th 2011 ] - Market Wire
Magellan Health Services Announces New Pharmacy Organization
[ Mon, Oct 10th 2011 ] - Market Wire
Health Net Receives Full URAC Accreditation for Disease Management
[ Mon, Oct 10th 2011 ] - Market Wire
Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
Allos Therapeutics Continues to Work Toward Completion of Merger with AMAG Pharmaceuticals
[ Mon, Oct 10th 2011 ] - Market Wire
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
United Therapeutics Subsidiary Enters Into Contra .. f Health for Award of up to $45 Million to Suppor
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®
[ Fri, Oct 07th 2011 ] - Market Wire
Poniard Pharmaceuticals Announces Effectiveness o .. n Statement for the Proposed Merger with ALLOZYNE
[ Fri, Oct 07th 2011 ] - Market Wire
NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Advitech and Natunola Announce Completion of Merg .. Private Placement and Change of Name to Botaneco
[ Fri, Oct 07th 2011 ] - Market Wire
Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. on Impax Laboratories Inc and Enzo Biochem, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
American Oriental Bioengineering, Inc. Submitted .. Deficiency with Respect to NYSE Listing Standard
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
US Domestic, Global Economic Outlook - Equity Res .. nomic Health, Inc. and EXACT Sciences Corporation
[ Thu, Oct 06th 2011 ] - Market Wire
SpectraScience to Introduce WavSTAT4 Optical Biop .. ean Gastroenterology Week Conference in Stockholm
[ Thu, Oct 06th 2011 ] - Market Wire
DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Theratechnologies Identifies Second Generation GRF Peptide and Initiates Pre-Clinical Studies
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Novadaq Reports 165 System Shipments During Third Quarter 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference
[ Thu, Oct 06th 2011 ] - Market Wire
Greystone Logistics Announces Record Sales in 4th Quarter
[ Thu, Oct 06th 2011 ] - Market Wire
The Ensign Group Acquires La Jolla Skilled Nursing Facility

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference


//health-fitness.news-articles.net/content/2011/ .. wsmakers-in-the-biotech-industry-conference.html
Published in Health and Fitness on Friday, October 14th 2011 at 14:10 GMT by Market Wire   Print publication without navigation


VALENCIA, Calif.--([ BUSINESS WIRE ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 18th Annual Newsmakers in the BioTech Industry Conference presented by Thomson Reuters and BioCentury on Friday, October 21, 2011 at 8:30am (ET) at the Millennium Broadway Hotel in New York, New York.

Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.


Publication Contributing Sources